* Program subject to change
Level: Introductory
Track: Economic Evaluation
Lorne Basskin, PharmD
Charleston University, Charleston, WV, USA
Level: Intermediate
Track: Real World Data & Information Systems
Blythe Adamson, PhD, MPH
Flatiron Health, New York, NY, USA
Rachael Sorg, MPH
Fredrik Borgström, MSc, PhD
Quantify Research and LIME/MMC, Karolinska Institutet, Stockholm, Sweden
Kirk Geale, MSc
Quantify Research AB, Stockholm, Sweden
Ingrid Lindberg, MSc
Quantify Research, Stockholm, Sweden
Track: Study Approaches
Nahila Justo, MBA, MPhil, MSc
Evidera, Stockholm, Sweden
Bradley Martin, PharmD, PhD, RPh
University of Arkansas for Medical Sciences, Little Rock, AR, USA
Track: Patient-Centered Research
Theresa Coles, PhD
Duke University, Durham, NC, USA
Track: Health Policy & Regulatory
Renato Dellamano, PhD
MME Europe & ValueVector (Value Added Business Strategies), Milan, Italy
Jack Mycka
Medical Marketing Economics LLC (MME), Montclair, NJ, USA
Track: Methodological & Statistical Research
Elisabeth Fenwick, PhD
Pharmerit International, Oxford, OXF, United Kingdom
Maarten J. IJzerman, PhD
Office of Health Economics, Melbourne, Australia
Deborah Marshall, PhD
University of Calgary, Calgary, AB, Canada
Uwe Siebert, MD, MPH, MSc, ScD
UMIT- University for Health Sciences, Medical Informatics and Technology, and Harvard Chan School of Public Health, Hall i.T., Austria
John E. Brazier, MSc PhD
University of Sheffield, Sheffield, United Kingdom
Helene Chevrou-Severac, PhD
Celgene International, Boudry, Switzerland
Andrew Lloyd, DPhil
Acaster Lloyd Consulting Ltd, London, United Kingdom
Jeremy Rassen, ScD
Aetion, Inc., New York, NY, USA
John D Seeger, PharmD, DrPH
Optum, Waltham, MA, USA
Finn Børlum Kristensen, MD, PhD
University of Southern Denmark, Hilleroed, Denmark
Erin Lopata, PharmD, MPH
Precision for Value, Pittsburgh, PA, USA
James F. Murray, PhD
Eli Lilly and Company, Carmel, IN, USA
Laura Pizzi, PharmD, MPH, RPh
Rutgers University, Piscataway, NJ, USA
Neil Hawkins, PhD, MSc, MBA, CStat
University of Glasgow, Glasgow, United Kingdom
Olivia Wu, PhD
James Lewsey, PhD
Gerd K. Rosenkranz, PhD
Medical University of Vienna, Vienna, Austria
Mark Connolly, PhD
Global Market Access Solutions, Groningen, GR, Netherlands
Nikos Kotsopoulos, PhD
Global Market Access Solutions, Geneva, GE, Switzerland
Baudouin Standaert, MD, PhD
GSK, Wavre, Belgium
Oleksandr Topachevsky, MSc, PGDip
Digital Health Outcomes, Kiev, Ukraine
Track: Health Technology Assessment
Uwe Siebert, MPH, MSc, ScD, MD
UMIT - University for Health Sciences, Medical Informatics, and Technology, Hall in Tirol, Austria
Shelby Corman, PharmD, MS
Pharmerit International, Bethesda, MD, USA
Mark S. Roberts, MD, MPP
University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA
Alexander Rieem Dun, MSc
Mark Larkin, PhD
Vitaccess Ltd, Oxford, United Kingdom
Annabel Nixon, BSc PhD
Chilli Consultancy Ltd, Salisbury, WIL, United Kingdom
Jon Spinage, BSc, CITP
Keith R. Abrams, PhD, MSc, CStat
University of Leicester, Leicester, United Kingdom
Christopher S. Hollenbeak, PhD
The Pennsylvania State University, Hershey, PA, USA
Rachele Busca, PharmD, MSc, MBA
W.L GORE, Verona, Italy
Richard Charter, MSc
ValueConnected, Basel, Switzerland
Michael Drummond, MCom, DPhil
University of York, York, United Kingdom
Stephen Hull, MHS
Hull Associates LLC, Rockland, MA, USA
Josh Carlson, MPH, PhD
University of Washington, Seattle, WA, USA
Louis P. Garrison, PhD
Adrian Towse, MA, MPhil
Office of Health Economics, London, United Kingdom
Nancy Devlin, PhD
University of Melbourne, Melbourne, VIC, Australia
Kevin Marsh, PhD
Evidera Ltd, Newport Pagell, BKM, Great Britain
Thor-Henrik Brodtkorb, PhD
RTI-HS Nordics, Ljungskile, Sweden
Stephanie R. Earnshaw, PhD, MS
RTI Health Solutions, Research Triangle Park, NC, USA
C. Daniel Mullins, PhD
University of Maryland, School of Pharmacy, Baltimore, MD, USA
Federico Augustovski, MSc, PhD
University of Buenos Aires, Buenos Aires, B, Argentina
Shelby D Reed, PhD, RPh
Monica Hernandez, MSc, PhD
University of Sheffield, Sheffield, NYK, United Kingdom
Andrea Manca, MSc, PhD
University of York, Heslington, York, United Kingdom
Allan Wailoo, MA, MSc, PhD
Level: Experienced
Please note: The statistical methods used to analyze multinational trial data and to transfer these data to a specific country are beyond the scope of this course.
Silvia Evers, PhD, LLM
Maastricht University, Maastricht, Netherlands
Manuela Joore, PhD
Maastricht University Medical Centre+, Maastricht, Netherlands
Francisco Javier Diez, PhD
Universidad Nacional de Eduación a Distancia (UNED), Madrid, Spain
Andrew Briggs, DPhil
Andrew Davies, MSc
Mondher Toumi, MD, MSc, PhD
Aix Marseille University, Marseille, France
Richard Grieve, PhD
London School of Hygiene and Tropical Medicine (LSHTM), London, United Kingdom
Noemi Kreif, PhD
Centre For Health Economics, York, United Kingdom
Stephen Oneill, MEconSc, PhD
National University of Ireland, Galway, Galway, Ireland
Guru Madhavan, PhD, MBA
National Academies of Science, Engineering, and Medicine, Washington, DC, USA
Charles E. Phelps, PhD, MBA
University of Rochester, Gualala, CA, USA
Rok Hren, PhD, MSc
University of Ljubljana, Ljubljana, Slovenia
Zoltan Kalo, PhD
Semmelweis University and Syreon Research Institute, Budapest, Hungary
Katarzyna Kolasa, PhD
Kozminski University, Warszawa, Poland
Anita Brogan, PhD
RTI Health Solutions, Manchester, LAN, United Kingdom
J. Jaime Caro, MDCM, FRCPC
Evidera, Waltham, MA, USA and University McGill, Canada, Waltham, MA, USA
Jörgen Möller, MSc
Evidera, Hammersmith, United Kingdom
Erik Koffijberg, PhD
University of Twente, Enschede, Netherlands
Lotte Steuten, PhD, MSc
Office of Health Economics, London, WA, United Kingdom
Sarah Goring, MSc
SMG Outcomes Research, Vancouver, BC, Canada
Jeroen P Jansen, PhD
Precision Xtract, Oakland, CA, USA